Paper32145488
Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration.
Anastasio NC and 7 others. Neuropharmacology, 2020. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration. Papers, record 32145488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32145488
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzazepines | Major topic |
| Cocaine | Major topic |
| Cocaine-Related Disorders | Major topic |
| Piperidines | Major topic |
| Urea | Major topic |
| Animals | |
| Dose-Response Relationship, Drug | |
| Drug Therapy, Combination | |
| Male | |
| Rats | |
| Rats, Sprague-Dawley | |
| Recurrence | |
| Self Administration | |
| Serotonin 5-HT2 Receptor Antagonists |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P50 DA033935 | NIDA NIH HHS | United States | P50DA033935 | PubMed | NIH RePORTER |
| U54 DA038999 | NIDA NIH HHS | United States | U54DA038999 | PubMed and NIH | NIH RePORTER |
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26926963 | Incubation of cocaine cue reactivity associates with neuroadaptations in the cortical serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system. | Neuroscience | 2016 | https://conductscience.org/library/papers/26926963 | PubMed |
| 2 | 14627998 | Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats. | Neuropsychopharmacology | 2004 | https://conductscience.org/library/papers/14627998 | PubMed |
| 3 | 19397907 | (1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity. | Eur J Pharmacol | 2009 | https://conductscience.org/library/papers/19397907 | PubMed |
| 4 | 28414422 | Synthesis and Structure-Activity Relationships of Tool Compounds Based on WAY163909, a 5-HT2C Receptor Agonist. | ACS Chem Neurosci | 2017 | https://conductscience.org/library/papers/28414422 | PubMed |
| 5 | 23939424 | Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence. | Neuropsychopharmacology | 2014 | https://conductscience.org/library/papers/23939424 | PubMed |
| 6 | 24618688 | Variation within the serotonin (5-HT) 5-HT₂C receptor system aligns with vulnerability to cocaine cue reactivity. | Transl Psychiatry | 2014 | https://conductscience.org/library/papers/24618688 | PubMed |
| 7 | 27475769 | Neurobiology of addiction: a neurocircuitry analysis. | Lancet Psychiatry | 2016 | https://conductscience.org/library/papers/27475769 | PubMed |
| 8 | 23946394 | Serotonin 2A receptors differentially contribute to abuse-related effects of cocaine and cocaine-induced nigrostriatal and mesolimbic dopamine overflow in nonhuman primates. | J Neurosci | 2013 | https://conductscience.org/library/papers/23946394 | PubMed |
| 9 | 26534942 | Lorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys. | J Pharmacol Exp Ther | 2016 | https://conductscience.org/library/papers/26534942 | PubMed |
| 10 | 21079923 | Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in rats. | Psychopharmacology (Berl) | 2011 | https://conductscience.org/library/papers/21079923 | PubMed |
| 11 | 8912799 | Failure of ritanserin to block cocaine cue reactivity in humans. | Drug Alcohol Depend | 1996 | https://conductscience.org/library/papers/8912799 | PubMed |
| 12 | 11082456 | Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior. | J Pharmacol Exp Ther | 2000 | https://conductscience.org/library/papers/11082456 | PubMed |
| 13 | 21575646 | Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues. | Neuropharmacology | 2011 | https://conductscience.org/library/papers/21575646 | PubMed |
| 14 | 12185211 | Addiction. | Annu Rev Psychol | 2003 | https://conductscience.org/library/papers/12185211 | PubMed |
| 15 | 23850573 | Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. | Neuropharmacology | 2014 | https://conductscience.org/library/papers/23850573 | PubMed |
| 16 | 22328576 | Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys. | J Pharmacol Exp Ther | 2012 | https://conductscience.org/library/papers/22328576 | PubMed |
| 17 | 12377394 | Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. | Neuropsychopharmacology | 2002 | https://conductscience.org/library/papers/12377394 | PubMed |
| 18 | 12427861 | Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. | J Neurosci | 2002 | https://conductscience.org/library/papers/12427861 | PubMed |
| 19 | 29555153 | Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT2A receptor (5-HT2AR) antagonist M100907. | Bioorg Med Chem Lett | 2018 | https://conductscience.org/library/papers/29555153 | PubMed |
| 20 | 17653111 | The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues. | Neuropsychopharmacology | 2008 | https://conductscience.org/library/papers/17653111 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40749271 | Lorcaserin modulation of semantic drug cue-elicited effective brain connectivity in persons with cocaine and opioid use disorders. | Psychiatry Res Neuroimaging | 2025 | https://conductscience.org/library/papers/40749271 | PubMed |
| 40035828 | The psychedelic (-)-2,5-dimethoxy-4-iodoamphetamine [(-)-DOI] demonstrates efficacy in reducing cocaine reward and motivation in male rats. | Psychopharmacology (Berl) | 2025 | https://conductscience.org/library/papers/40035828 | PubMed |
| 39433903 | Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats. | Mol Psychiatry | 2025 | https://conductscience.org/library/papers/39433903 | PubMed |
| 39200714 | Chronic Cocaine Use and Parkinson's Disease: An Interpretative Model. | Int J Environ Res Public Health | 2024 | https://conductscience.org/library/papers/39200714 | PubMed |
| 39096558 | Novel therapeutics in development for the treatment of stimulant-use disorder. | Curr Opin Neurobiol | 2024 | https://conductscience.org/library/papers/39096558 | PubMed |
| 38677331 | Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice. | Behav Brain Res | 2024 | https://conductscience.org/library/papers/38677331 | PubMed |
| 36627204 | 3,4-Methylenedioxypyrovalerone High-Responder Phenotype as a Tool to Evaluate Candidate Medications for Stimulant Use Disorder. | J Pharmacol Exp Ther | 2023 | https://conductscience.org/library/papers/36627204 | PubMed |
| 36588704 | Heightened cocaine-seeking in male rats associates with a distinct transcriptomic profile in the medial prefrontal cortex. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36588704 | PubMed |
| 35221941 | Blockade of 5-Hydroxytryptamine 2A Receptor Attenuates Precipitation of Naloxone-Induced Withdrawal Symptoms in Opioid-Exposed Mice. | Front Behav Neurosci | 2021 | https://conductscience.org/library/papers/35221941 | PubMed |
| 35183539 | Sex-specific role for serotonin 5-HT2A receptor in modulation of opioid-induced antinociception and reward in mice. | Neuropharmacology | 2022 | https://conductscience.org/library/papers/35183539 | PubMed |
| 34916591 | Role of neuropeptide neuromedin U in the nucleus accumbens shell in cocaine self-administration in male rats. | Neuropsychopharmacology | 2022 | https://conductscience.org/library/papers/34916591 | PubMed |
| 34461148 | Confronting the challenge of failed translation in medications development for substance use disorders. | Pharmacol Biochem Behav | 2021 | https://conductscience.org/library/papers/34461148 | PubMed |
| 34454912 | Covid-19 interface with drug misuse and substance use disorders. | Neuropharmacology | 2021 | https://conductscience.org/library/papers/34454912 | PubMed |
| 33929084 | The 5-HT2C receptor as a therapeutic target for alcohol and methamphetamine use disorders: A pilot study in treatment-seeking individuals. | Pharmacol Res Perspect | 2021 | https://conductscience.org/library/papers/33929084 | PubMed |
| 33862029 | Converging vulnerability factors for compulsive food and drug use. | Neuropharmacology | 2021 | https://conductscience.org/library/papers/33862029 | PubMed |
| 33389797 | 5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers. | Addict Biol | 2021 | https://conductscience.org/library/papers/33389797 | PubMed |
| 32839526 | Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder. | Neuropsychopharmacology | 2020 | https://conductscience.org/library/papers/32839526 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32145488
GET https://conductscience.org/api/papers/v1/32145488/references?page=2